Assessment of osteoporotic fracture risk in patients with chronic obstructive pulmonary disease

Authors

DOI:

https://doi.org/10.33448/rsd-v10i5.14816

Keywords:

COPD; Osteoporosis; Osteoporotic Fractures.

Abstract

Objective: To evaluate the risk of osteoporotic fracture and the indication of treatment for osteoporosis in patients with Chronic Obstructive Pulmonary Disease (COPD) through FRAX and NOGG. Methods: Descriptive, observational and cross-sectional study with a convenience sample carried out in a charity hospital in the city of Aracaju-SE. COPD patients were selected for the study and paired with healthy individuals. Results: The study sample consisted of 174 individuals, 87 in the COPD group (DG) and 87 in the control group (CG). Through clinical FRAX for absolute risk of major osteoporotic fracture for all study volunteers, 3 (3.44%) of the DG had indicative treatment value for osteoporosis and no participant in the CG. For hip fractures, it was found that 36 (41.4%) in the GD and 12 (13.8%) volunteers in the CG would have an indication for treatment. Through the NOGG methodology, 44 (50.6%) of the patients in the GD and 4 (4.6%) of the volunteers in the CG had an indication for treatment, 38 (43.7%) of the GD and 58 (66.6%) ) of the CG had an indication to perform bone densitometry. Conclusions: The data demonstrated that COPD increases the risk for osteoporotic fractures, especially in women and the elderly. Through NOGG it was possible to identify the risk of fracture with a higher positive and negative predictive value when compared to FRAX.

References

Adas-Okuma, M. G., Maeda, S. S., Gazzotti, M. R., Roco, C. M., Pradella, C. O., Nascimento, O. A., ... & Lazaretti-Castro, M. (2020). COPD as an independent risk factor for osteoporosis and fractures. Osteoporosis International, 31(4), 687-697.

Arruda, M. F., Pereira, L. G. A., Fávero, T. M., Cassettari, L. L., & de Souza Junior, A. P. (2013). Perfil do Uso do Programa Avaliacional Sapori em Paralelo à Necessidade da Densitometria Mineral Óssea em Amostra de Mulheres Pós-Menopáusicas da Cidade de Catanduva-SP. Saúde e Pesquisa, 6(2).

Compston, J., Cooper, A., Cooper, C., Gittoes, N., Gregson, C., Harvey, N., ... & Vine, N. (2017). UK clinical guideline for the prevention and treatment of osteoporosis. Archives of osteoporosis, 12(1), 43.

Curtis, E. M., Woolford, S., Holmes, C., Cooper, C., & Harvey, N. C. (2020). General and Specific Considerations as to why Osteoporosis-Related Care Is Often Suboptimal. Current osteoporosis reports, 18(1), 38-46.

Dam, T. T., Harrison, S., Fink, H. A., Ramsdell, J., & Barrett-Connor, E. (2010). Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma. Osteoporosis International, 21(8), 1341-1349.

Dennison, E. M., Compston, J. E., Flahive, J., Siris, E. S., Gehlbach, S. H., Adachi, J. D., ... & Glow Investigators. (2012). Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone, 50(6), 1288-1293.

Global Initiative for Chronic Obstructive Lung Disease - GOLD. https://goldcopd.org/. Accessed April 11, 2019

Gudmundsson, H. T., Hansen, K. E., Halldorsson, B. V., Ludviksson, B. R., & Gudbjornsson, B. (2019). Clinical decision support system for the management of osteoporosis compared to NOGG guidelines and an osteology specialist: a validation pilot study. BMC medical informatics and decision making, 19(1), 1-8.

Han, M. K., Dransfield, M. T., & Martinez, F. J. (2018). Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging. Uptodate. May, 14.

Kanis, J. A., Harvey, N. C., Johansson, H., Liu, E., Vandenput, L., Lorentzon, M., ... & McCloskey, E. V. (2020). A decade of FRAX: how has it changed the management of osteoporosis?. Aging clinical and experimental research, 32(2), 187-196.

Lewiecki, E. M., & Schmader, K. E. (2021). Osteoporotic fracture risk assessment. Uptodate. Mar, 09

Lin, C. H., Chen, K. H., Chen, C. M., Chang, C. H., Huang, T. J., & Lin, C. H. (2018). Risk factors for osteoporosis in male patients with chronic obstructive pulmonary disease in Taiwan. PeerJ, 6, e4232.

Okazaki, R., Watanabe, R., & Inoue, D. (2016). Osteoporosis associated with chronic obstructive pulmonary disease. Journal of bone metabolism, 23(3), 111.

Park, H. Y., Lee, H., Kang, D., Choi, H. S., Ryu, Y. H., Jung, K. S., ... & Yoo, K. H. (2021). Understanding racial differences of COPD patients with an ecological model: two large cohort studies in the US and Korea. Therapeutic advances in chronic disease, 12, 2040622320982455.

Pegoraro, T., de Oliveira Padilha, E. L., Conti, C. F. B., & da Silva, L. M. (2017). Quantificação do risco de fraturas através da ferramenta FRAX em pacientes com doença renal crônica em hemodiálise. Arquivos Catarinenses de Medicina, 46(3), 39-58.

Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. [e-book]. Santa Maria. Ed. UAB/NTE/UFSM. https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1.

Pereira, E. N. L. (2017). Análise da distribuição dos equipamentos de densitometria óssea no Brasil: importância da gestão eficiente de tecnologias em saúde.

Radominski, S. C., Bernardo, W., Paula, A. P. D., Albergaria, B. H., Moreira, C., Fernandes, C. E., ... & Borba, V. Z. (2017). Diretrizes brasileiras para o diagnóstico e tratamento da osteoporose em mulheres na pós-menopausa. Revista Brasileira de Reumatologia, 57, s452-s466.

Rosen, H. N., Drezner, M. K., Rosen, C. J., Schmader, K. E., & Mulder, J. E. (2017). Overview of the management of osteoporosis in postmenopausal women. Monografía en Internet]. Uptodate.

Rothnie, K. J., Connell, O., Müllerová, H., Smeeth, L., Pearce, N., Douglas, I., & Quint, J. K. (2018). Myocardial infarction and ischemic stroke after exacerbations of chronic obstructive pulmonary disease. Annals of the American Thoracic Society, 15(8), 935-946.

Saag, K., & Adler, R. A. (2018). Glucocorticoid-induced osteoporosis. Primer on the metabolic bone diseases disorder of mineral metabolism. 9th Ed. New Jersey, USA: Wiley, 467-473.

Schwab, P., Dhamane, A. D., Hopson, S. D., Moretz, C., Annavarapu, S., Burslem, K., ... & Kaila, S. (2017). Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population. International journal of chronic obstructive pulmonary disease, 12, 735.

Silva, D. D. C. (2019). Indicação de tratamento para osteoporose em idosos ambulatoriais do Hospital Universitário da Universidade Federal de Sergipe.

Silva, D. M. W., Borba, V. Z. C., & Kanis, J. A. (2017). Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil. Archives of osteoporosis, 12(1), 1-8.

Published

27/04/2021

How to Cite

SANTOS, D. S.; PEREIRA, F. de A.; LINS, J. S.; SANTANA, I. A. de O. .; MENDONÇA, M. N. P. S.; BARBOSA, B. P. R. .; BARRETO , I. C. R. .; SANTOS NETO, J. J. dos .; BARCELOS, I. S. de . Assessment of osteoporotic fracture risk in patients with chronic obstructive pulmonary disease. Research, Society and Development, [S. l.], v. 10, n. 5, p. e15910514816, 2021. DOI: 10.33448/rsd-v10i5.14816. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/14816. Acesso em: 25 apr. 2024.

Issue

Section

Health Sciences